EA202191370A1 - Фармацевтическая композиция и способ ее получения - Google Patents

Фармацевтическая композиция и способ ее получения

Info

Publication number
EA202191370A1
EA202191370A1 EA202191370A EA202191370A EA202191370A1 EA 202191370 A1 EA202191370 A1 EA 202191370A1 EA 202191370 A EA202191370 A EA 202191370A EA 202191370 A EA202191370 A EA 202191370A EA 202191370 A1 EA202191370 A1 EA 202191370A1
Authority
EA
Eurasian Patent Office
Prior art keywords
carbon atoms
pharmaceutical composition
group
alkyl group
represent
Prior art date
Application number
EA202191370A
Other languages
English (en)
Russian (ru)
Inventor
Тацуя Мураками
Такехиро Ямане
Сироу СОНОКЕ
Ацуси Кано
Со Тойонага
Original Assignee
Фуджифилм Корпорэйшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фуджифилм Корпорэйшн filed Critical Фуджифилм Корпорэйшн
Publication of EA202191370A1 publication Critical patent/EA202191370A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA202191370A 2018-12-14 2019-12-13 Фармацевтическая композиция и способ ее получения EA202191370A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018234688 2018-12-14
PCT/JP2019/049018 WO2020122242A1 (ja) 2018-12-14 2019-12-13 医薬組成物及びその製造方法

Publications (1)

Publication Number Publication Date
EA202191370A1 true EA202191370A1 (ru) 2021-09-16

Family

ID=71076508

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191370A EA202191370A1 (ru) 2018-12-14 2019-12-13 Фармацевтическая композиция и способ ее получения

Country Status (2)

Country Link
EA (1) EA202191370A1 (ja)
WO (1) WO2020122242A1 (ja)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0812964A2 (pt) * 2007-06-25 2014-12-16 Tibotec Pharm Ltd Forma de dosagem farmacêutica oral sólida
MX2010011963A (es) * 2008-05-02 2010-12-06 Gilead Sciences Inc Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
WO2010006697A2 (en) * 2008-06-30 2010-01-21 Tibotec Pharmaceuticals Powders for reconstitution
WO2015136294A1 (en) * 2014-03-13 2015-09-17 Cipla Limited Pharmaceutical composittion comprising rilpivirine
TWI718102B (zh) * 2014-08-08 2021-02-11 日商中外製藥股份有限公司 ４環性化合物的非晶質體

Also Published As

Publication number Publication date
WO2020122242A1 (ja) 2020-06-18

Similar Documents

Publication Publication Date Title
AR028531A1 (es) Compuestos organicos
EA200701640A1 (ru) Новые соединения с терапевтическим эффектом
HUP0402454A2 (hu) Szubsztituált kinazolinszármazékok mint az aurora kinázok inhibitorai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BR0112856A (pt) Método para o tratamento dos distúrbios, composto ou um sal ou solvato deste, processo para a preparação dos mesmos, composição farmacêutico, método de tratamento e/ou profilaxia de um ou mais dos distúrbios, uso de um composto, e, método para o tratamento de diabetes, grande depressão, depressão manìaca, ansiedade, esquizofrenia e distúrbios do sono, em mamìferos humanos e não humanos
ATE431345T1 (de) Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
WO2003080580A3 (en) Quinoline derivatives and their use as 5-ht6 ligands
AR060316A1 (es) Azaindoles de utilidad como inhibidores de janus quinasas
HUP9802694A1 (hu) Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP9801357A2 (hu) Imidazolin-, imidazol-, oxazolin- és tiazolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
MX2015008971A (es) Derivados de pirimidina pirido- o pirrolo-fusionados como inhibidores de autotaxina para tratar dolor.
ATE487474T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
EA201000017A1 (ru) Предварительная композиция серного цемента и способ приготовления предварительной композиции серного цемента
TW200637559A (en) 3-propenylcefem derivative
AR031597A1 (es) Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3
RU2020108470A (ru) Аддитивная композиция для культуральной среды, аддитивное соединение для культуральной среды и способ культивирования клеток или тканей с использованием этой композиции и соединения
RU2328490C2 (ru) Производные бензоксазинонов и фармацевтическая композиция на их основе
MX2014004144A (es) Derivados de etinilo como moduladores alostericos del receptor de glutamato metabotropico del subtipo 5 (mglur5).
ATE540675T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
RU2007123251A (ru) Производные хромана и их применение в качестве лигандов 5-нт рецептора
RU2009125439A (ru) Комбинация ингибитора гда и антиметаболита
ATE450496T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
ATE479690T1 (de) Thienoä2,3-büpyridin derivate
MY144609A (en) 2-methyl-4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives